Why would SUPG agree to a low price right here? Without management approval, acquirer would have a small chance of buying this company. There is a posion pill and if EU data is positive, well on the low side were looking at 400M WW sales of dacogen. Supg will not sell, specially if MP-470 is the real deal and S110 could skip a ph2 (doubt this). Remember insiders didn't sell one share at the recent highs, what makes you think they would now?